Processes Webinar | Active/Bioactive Ingredient-Based Nanomedicines: From Design to In Vitro Evaluation in Advanced 2D/3D Disease Models
the chair
21st Processes Webinar
Active/Bioactive Ingredient-Based Nanomedicines: From Design to In Vitro Evaluation in Advanced 2D/3D Disease Models
It is my great pleasure to welcome you to this webinar, “Active/Bioactive Ingredient-Based Nanomedicines: From Design to In Vitro Evaluation in Advanced 2D/3D Disease Models.”
We have three distinguished speakers — Dr. Ghosal, Dr. Formiga and Dr. Romero— who will share recent advances. Their presentations will cover novel drug delivery systems developed through advanced nanofabrication techniques, the biophysical assessment of monoclonal antibody-conjugated nanoparticles for lung delivery, and the use of lipids from halophilic archaea as unique biomaterials for the design of innovative nanomedicines. Together, these contributions highlight the diversity and scientific depth of the field, ranging from nanomaterial design and fabrication to advanced strategies for targeted delivery and characterization, as well as from fundamental design principles to translational in vitro methodologies.
Dr. Morilla and I would like to thank MDPI for hosting this webinar, and all participants for joining us. We hope this session fosters meaningful scientific exchange, inspires new collaborations, and contributes to the continued advancement of active and bioactive nanomedicines.
We would also like to take this opportunity to remind participants that submissions to the Special Issue associated with this webinar are welcome. The deadline for manuscript submission is June 30, 2026, although some flexibility is possible.
Date: 15 April 2026
Time: 1:00 pm EDT | 7:00 pm CEST
Webinar ID: 863 7370 6084
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chair
Meet Our Speakers
Dr. Kajal Ghosal
Department of Pharmaceutical Technology, Jadavpur University, Kolkata-700032, India;
Dr. Kajal Ghosal has worked as an academic for the last 18 years. Presently, she is working at the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India, as an assistant professor. She has done her undergraduate, postgraduate and PhD work in the field of pharmaceutical technology from same university. She has received the prestigious Kothari Postdoctoral fellowship in India for doing a postdoc. She has carried out her postdoctoral research at the Central European Institute of Technology in the Czech Republic. She has also visited the University of Novi Sad, Serbia, and the University of Münster, Germany, under the European COST action. She has published one book on electrospinning from the Royal Society of Chemistry and another two books on polymer science from RSC and Elsevier. She has collaborated with many international scientists from the USA, Egypt, Quatar, the Czech Republic, Slovakia, Australia, Italy, Argentina, Taiwan, France and Poland. She has been awarded a visiting fellowship for carrying out short-term research at the Slovak Academy of Science and at IPPT-PAN, Warsaw, Poland. She has published 52 research and review articles in peer-reviewed journals. Her research areas are magnetite nanoparticles; electrospinning; drug delivery, formulation development; microemulsion/nanoemulsion; solubility enhancement techniques; nanotubes; nanofibers; transdermal drug delivery systems; and nano-composites
Dr. Fabio Formiga
1. Oswaldo Cruz Foundation (FIOCRUZ), Brazil, 2. Faculty of Medical Sciences, University of Pernambuco (FCM/UPE), Brazil;
Dr. Fabio Formiga is a research scientist at the Oswaldo Cruz Foundation (FIOCRUZ), and he also holds a tenured Associate Professor position at the Faculty of Medical Sciences of the University of Pernambuco (FCM/UPE) in Brazil. He obtained a PhD in pharmaceutical technology from the University of Navarra in Spain, and he has worked as a visiting scholar at the Niels Bohr Institute, University of Copenhagen. In 2024, he completed a visiting postdoctoral fellowship at Brigham and Women's Hospital, Harvard Medical School. He is a co-founder and past president of the Brazilian chapter of the Controlled Release Society (CRS), and a member of the Nanomedicine and Nano-Scale Delivery Focus Group/CRS. Member of the editorial board of Drug Delivery and Translational Research (Springer) and Frontiers in Medical Technology (Frontiers). Dr. Formiga has coordinated RD&I projects in collaboration with the Institute Pasteur of Montevideo/UY (Pasteur Network), Rutherford Appleton Laboratory/UK (STFC/UKRI), University of Coimbra/PT (CAPES/FCT), University of Copenhagen/DK (ERASMUS/EU), and BWH/Harvard (CNPq). He is a member of the Brazilian Association of Pharmaceutical Sciences (ABCF) and the European Foundation for Clinical Nanomedicine (CLINAM/Basel). National Research Award, by the Spanish Society of Industrial and Galenic Pharmacy-SEFIG (2013), and the Benjamin Gilbert Award, by Fiocruz (2017). Science, Technology and Innovation Award for the Brazilian Public Health System (CT&I SUS/CNPq 2025). His research interests include pharmaceutics; drug delivery; and nanomedicine.
Dr. Eder Lilia Romero
Nanomedicine Research and Development Centre (NARD), Science and Technology Department, National University of Quilmes, Argentina;
Dr. Eder Lilia Romero is a Tenured Full Professor of Nanobiotechnology at the National University of Quilmes (UNQ), where she also serves as the Director of the Nanomedicine R&D Center within the Department of Science and Technology. A Principal Investigator at CONICET, she founded and directed the Postgraduate Specialization in Nanotechnology Applied to Health (ENAS) at UNQ. Her research focuses on the preclinical design and development of advanced drug delivery systems. Her primary areas of expertise include inhalable nanomedicines for pulmonary anti-inflammatory, anti-tumor, and anti-fibrotic therapies; ocular instillable nanomedicines for dry eye disease; and nanovaccines based on nanoarchaeosomes for the delivery of TLR 3 and 7 agonists. Additionally, she leads research into antimicrobial nanomedicines designed to induce wound healing in chronic ulcers. She has published over 90 scientific articles and 9 book chapters, maintaining a strong bibliometric impact (as of March 2026: h-index 30 Scopus / 33 Google Scholar). Beyond her research, she is a dedicated mentor, having supervised 8 PhD theses and 7 CONICET researchers. Her expertise is frequently sought by regulatory and industrial bodies; she serves as an advisor to ANMAT on nanomedical regulations and consults for pharmaceutical companies on product development. She is currently a member of the Editorial Boards for Precision Nanomedicine and BMC Research Notes.
Sponsors and Partners
organizer
This webinar highlighted innovative drug delivery platforms, including magnetite nanoparticles, nanosponges, and nanofibers, as well as monoclonal antibody-conjugated nanoparticles for lung delivery and archaeal lipid-based biomaterials for next-generation nanomedicine design. A key focus was placed on the rational design of nanomedicines, their physicochemical characterization, and their in vitro evaluation.
The webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe" at the top of the page.
Processes